Eikon Therapeutics, Inc. went public at $18.00 a share
It sold 21,177,600 shares on Nasdaq Global Select Market under the ticker EIKN and raised $381.2 million before costs.
Final prospectus (424B4) filed February 5, 2026
The terms
-
Offered
21,177,600 shares
Checked
Source
“We are offering 21,177,600 shares of our common stock.”
A model read this, and code confirmed the quote appears in the filing. -
Price per share
$18.00
Checked
Source
“The initial public offering price is $18.00 per share.”
A model read this, and code confirmed the quote appears in the filing. -
Raised
$381,196,800before fees and costs
Checked
Source and check
Shares × price = 21,177,600 × $18.00 = $381,196,800. They match.
“Initial public offering price | $18.00 | $381,196,800”
A model read this, and code confirmed the quote appears in the filing. -
Bank fee
$26,683,776$1.26 a share, 7.0% of the raise
Checked
Source
“Underwriting discounts and commissions(1) | $1.26 | $26,683,776”
A model read this, and code confirmed the quote appears in the filing. -
Lead banks
J.P. Morgan, Morgan Stanley, BofA Securities, Cantor, Mizuho
From the prospectus
Source
“J.P. Morgan* | Morgan Stanley* | BofA Securities | Cantor | Mizuho”
A model read this, and code confirmed the quote appears in the filing. -
Trades as
EIKN on Nasdaq Global Select Market
Checked
Source
“Our common stock has been approved for listing on the Nasdaq Global Select Market, or Nasdaq, under the trading symbol “EIKN.””
A model read this, and code confirmed the quote appears in the filing. -
Extra for the banks
Up to 3,176,640 sharesan option the banks may use
From the prospectus
Source
“We have granted the underwriters an option for a period of 30 days to purchase up to 3,176,640 additional shares of our common stock from us at the initial public offering price, less underwriting discounts and commissions.”
A model read this, and code confirmed the quote appears in the filing. - Final prospectus filed February 5, 2026
Not investment advice.Open the filing on SEC.gov
Who owns the company after the IPO
From the prospectus 21,177,600 of 53,984,337 shares outstanding after the offering (39.2%).
Where Eikon Therapeutics, Inc. sits among the last 12 months
Each bubble is one IPO. Bigger and higher means more money raised. The scale grows by ten times at each line.
New to these terms? How to read an IPO.